药店岂能“一药两价”

Core Insights - The phenomenon of "one drug, two prices" in pharmacies is drawing significant consumer attention, particularly regarding the price discrepancies between in-store purchases using health insurance cards and online prices [1][2] - Consumers are struggling to understand the rationale behind these price differences, especially when they are using funds from their health insurance accounts [1] - The issue is partly attributed to the longer settlement periods associated with health insurance payments, which may lead pharmacies to pass on costs to consumers [1] Group 1 - The media has reported on a consumer's experience of purchasing medication at a pharmacy with a health insurance card, only to find that the prices were significantly higher than those available online [1] - There is a growing concern that some pharmacies may be exploiting the "one drug, two prices" model as a means to siphon off health insurance funds, especially if other pharmacies follow suit [1] - The National Healthcare Security Administration has initiated measures to improve the efficiency of health insurance settlements with designated medical institutions, which may help address these pricing discrepancies [1] Group 2 - The ongoing issue of "one drug, two prices" cannot continue, and there is a call for stricter enforcement, improved settlement efficiency, and heightened public awareness [2] - Pharmacies that focus on exploiting consumers rather than providing competitive pricing may face the risk of being driven out of the market due to increasing competition from online sales and other pharmacies [2]